ArticleJournal of neuromuscular diseases2018

Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany.

Astrid Pechmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.